Global Restless Legs Syndrome Market Size study, by Type (Primary Restless Legs Syndrome, Secondary Restless Legs Syndrome), Treatment Type (Medication and Devices, Surgery), and Regional Forecasts 2022-2028
- BIZ4983338
- 200 Pages
- June 2022
- Pharmaceuticals
According to research released by Frontiers Media S.A. in March 2022, the reported prevalence of restless legs syndrome ranged between 3.9 percent and 14.3 percent, Moreover, 37.3 million Americans, or around 11.3 percent of the country's population, have diabetes, according to data from the Centers for Disease Control and Prevention released in 2022. However, side Effects Associated with Restless Syndrome Treatments impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Restless Legs Syndrome Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to rising prevalence of restless legs syndrome and rising affordability of drugs. However, Asia Pacific is expected to be the fastest growing region due to growing prevalence of neurological disorders and rising expenditure to develop healthcare infrastructure.
Major market players included in this report are:
Boehringer Ingelheim International GmbH
Arbor Pharmaceuticals, LLC
Psychocare Health Private Limited
Sun Pharmaceutical Industries Ltd
Viatris Inc
Restiffic
UCB S.A
Relegs
Glenmark Pharmaceutical
Noctrix Health, Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Primary Restless Legs Syndrome
Secondary Restless Legs Syndrome
By Treatment Type:
Surgery
Medication and Devices
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Restless Legs Syndrome Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Restless Legs Syndrome Market, by region, 2020-2028 (USD Million)
1.2.2. Restless Legs Syndrome Market, by Type, 2020-2028 (USD Million)
1.2.3. Restless Legs Syndrome Market, by Treatment Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Restless Legs Syndrome Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Restless Legs Syndrome Market Dynamics
3.1. Restless Legs Syndrome Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. High Unmet Need of Treatment and Increasing Geriatric Population
3.1.1.2. Rise in Prevalence of Restless Leg Syndrome
3.1.2. Market Challenges
3.1.2.1. Side Effects Associated with Restless Syndrome Treatments
3.1.2.2. Rising introduction of generic drugs and unfavourable reimbursement scenario
3.1.3. Market Opportunities
3.1.3.1. R&D Activities for Launch of Novel Products
3.1.3.2. Rising expenditure on the development of healthcare infrastructure
Chapter 4. Global Restless Legs Syndrome Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Restless Legs Syndrome Market, by Type
6.1. Market Snapshot
6.2. Global Restless Legs Syndrome Market by Type, Performance - Potential Analysis
6.3. Global Restless Legs Syndrome Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
6.4. Restless Legs Syndrome Market, Sub Segment Analysis
6.4.1. Primary Restless Legs Syndrome
6.4.2. Secondary Restless Legs Syndrome
Chapter 7. Global Restless Legs Syndrome Market, by Treatment Type
7.1. Market Snapshot
7.2. Global Restless Legs Syndrome Market by Treatment Type, Performance - Potential Analysis
7.3. Global Restless Legs Syndrome Market Estimates & Forecasts by Treatment Type, 2018-2028 (USD Million)
7.4. Restless Legs Syndrome Market, Sub Segment Analysis
7.4.1. Surgery
7.4.2. Medication and Devices
Chapter 8. Global Restless Legs Syndrome Market, Regional Analysis
8.1. Restless Legs Syndrome Market, Regional Market Snapshot
8.2. North America Restless Legs Syndrome Market
8.2.1. U.S. Restless Legs Syndrome Market
8.2.1.1. Type breakdown estimates & forecasts, 2018-2028
8.2.1.2. Treatment Type breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Restless Legs Syndrome Market
8.3. Europe Restless Legs Syndrome Market Snapshot
8.3.1. U.K. Restless Legs Syndrome Market
8.3.2. Germany Restless Legs Syndrome Market
8.3.3. France Restless Legs Syndrome Market
8.3.4. Spain Restless Legs Syndrome Market
8.3.5. Italy Restless Legs Syndrome Market
8.3.6. Rest of Europe Restless Legs Syndrome Market
8.4. Asia-Pacific Restless Legs Syndrome Market Snapshot
8.4.1. China Restless Legs Syndrome Market
8.4.2. India Restless Legs Syndrome Market
8.4.3. Japan Restless Legs Syndrome Market
8.4.4. Australia Restless Legs Syndrome Market
8.4.5. South Korea Restless Legs Syndrome Market
8.4.6. Rest of Asia Pacific Restless Legs Syndrome Market
8.5. Latin America Restless Legs Syndrome Market Snapshot
8.5.1. Brazil Restless Legs Syndrome Market
8.5.2. Mexico Restless Legs Syndrome Market
8.6. Rest of The World Restless Legs Syndrome Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Boehringer Ingelheim International GmbH
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Arbor Pharmaceuticals, LLC
9.2.3. Psychocare Health Private Limited
9.2.4. Sun Pharmaceutical Industries Ltd
9.2.5. Viatris Inc
9.2.6. Restiffic
9.2.7. UCB S.A
9.2.8. Relegs
9.2.9. Glenmark Pharmaceutical
9.2.10. Noctrix Health, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
TABLE 1. Global Restless Legs Syndrome Market, report scope
TABLE 2. Global Restless Legs Syndrome Market estimates & forecasts by region 2018-2028 (USD Million)
TABLE 3. Global Restless Legs Syndrome Market estimates & forecasts by Type 2018-2028 (USD Million)
TABLE 4. Global Restless Legs Syndrome Market estimates & forecasts by Treatment Type 2018-2028 (USD Million)
TABLE 5. Global Restless Legs Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 6. Global Restless Legs Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Restless Legs Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Restless Legs Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Restless Legs Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Restless Legs Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Restless Legs Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Restless Legs Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Restless Legs Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Restless Legs Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. U.S. Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 17. U.S. Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. Canada Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 19. Canada Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. Canada Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. UK Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 22. UK Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. UK Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. Germany Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 25. Germany Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. Germany Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. RoE Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 28. RoE Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. RoE Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. China Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 31. China Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. China Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. India Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 34. India Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. India Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. Japan Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 37. Japan Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. Japan Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. RoAPAC Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 40. RoAPAC Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. RoAPAC Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. Brazil Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 43. Brazil Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Brazil Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Mexico Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 46. Mexico Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. Mexico Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. RoLA Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 49. RoLA Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. RoLA Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. Row Restless Legs Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 52. Row Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. Row Restless Legs Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. List of secondary sources, used in the study of global Restless Legs Syndrome Market
TABLE 55. List of primary sources, used in the study of global Restless Legs Syndrome Market
TABLE 56. Years considered for the study
TABLE 57. Exchange rates considered
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
